Status:

UNKNOWN

Bizarreness and Anomalous Self Experiences in Schizophrenia

Lead Sponsor:

University Hospital, Toulouse

Conditions:

Schizophrenia

Eligibility:

All Genders

18+ years

Brief Summary

Several authors suggest that the specific experience felt in clinical encounter, called Praecox Feeling, is directly linked to the psychopathology of Schizophrenia. However, determining factors of th...

Detailed Description

Several authors suggest that the specific experience felt in clinical encounter, called Praecox Feeling, is directly linked to the psychopathology of Schizophrenia. However, subjective, cognitive or n...

Eligibility Criteria

Inclusion

  • People with a diagnosis of schizophrenia according to the Diagnostic and Statistical Manual of Mental Disorders (DSM-V) criteria.
  • Psychiatric medical situation judged clinically stable : no change of main antipsychotic in treatment in last 15 days.
  • People who has given his non-opposition
  • Patients affiliated to a social security system

Exclusion

  • Previous meeting of the participant with one of the investigators involved in the clinical assessment and scoring of the study scales.
  • Person with a moderate to severe intellectual disability (clinical criteria).
  • Person with a neurological pathology with cognitive impact
  • Patients with legal protection

Key Trial Info

Start Date :

July 12 2023

Trial Type :

OBSERVATIONAL

Allocation :

ESTIMATED

End Date :

September 1 2024

Estimated Enrollment :

12 Patients enrolled

Trial Details

Trial ID

NCT05966610

Start Date

July 12 2023

End Date

September 1 2024

Last Update

July 28 2023

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

CHU Toulouse

Toulouse, France